Zhejiang Starry Pharmaceutical Co.,Ltd.

SSE:603520.SS

10.42 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -49.10344.232-71.926329.768253.597182.92195.53981.42575.90673.46767.02662.834.99967.331
Depreciation & Amortization 222.172179.554160.442154.965126.229108.97284.67972.35165.36257.77750.94443.53636.22624.115
Deferred Income Tax 0-0.594-6.73-8.917-0.6782.016-2.03-0.06-0.932-1.9120000
Stock Based Compensation 004.14602.728000000000
Change In Working Capital -138.417-311.3-417.272-75.408-283.267-166.787-55.08-162.286-156.463-78.815-2.916-60.2237.21-147.07
Accounts Receivables -359.659160.474-187.877-349.61-131.982-146.574-120.322-149.771-1.265-60.51132.467-69.85459.4750
Inventory -2.186-465.852-281.593-9.523-202.637-68.114-49.9110.211-106.015-28.796-48.07728.485-48.987-55.948
Accounts Payables 0-5.96258.928292.64252.0345.885117.183-12.667-48.25112.4040000
Other Working Capital 223.4290.04-6.73-8.917-0.6782.016-5.169-162.497-50.448-50.01945.161-88.70856.197-91.122
Other Non Cash Items 158.85134.235252.96699.51475.87121.66266.69826.61422.87542.4528.94628.8824.90714.55
Operating Cash Flow 193.50246.126-78.374508.839174.479246.768191.83618.1057.6894.879144.00174.993103.342-41.073
Investing Activities:
Investments In Property Plant And Equipment -480.619-266.225-472.184-303.879-153.166-133.277-162.403-90.615-188.511-244.655-206.761-188.422-138.278-130.608
Acquisitions Net 018.88430.93-21.71114.015134.606-782.21411.0490.1983.8120000
Purchases Of Investments -11.3-28-56-32.029-80.736-2-2-160-1800000
Sales Maturities Of Investments 021.37495.4961.9837.081.81.821.2910.4980.2070.1150.4040.2420.422
Other Investing Activites 1.184-1.59469.5473.355-128.956-133.27713.24486.72-58.7493.81245.933.81913.05819.889
Investing Cash Flow -490.735-255.56-332.219-282.283-311.763-132.148-931.57317.395-264.564-240.636-160.715-184.198-124.977-110.296
Financing Activities:
Debt Repayment -802.414-152.089548.071-156.265113.68831.15476.87299.26851.517305.15972.004144.4559.847143.782
Common Stock Issued 002.8461.40507.14900000000
Common Stock Repurchased 0-10.183-2.846-1.4050-7.14900000000
Dividends Paid -128.425-68.251-122.438-122.435-58.676-35.924-108.394-88.615-84.857-90.045-63.928-41.701-22.978-14.153
Other Financing Activities 1,229.868303.35133.11255.477589.561191.834335.8160280.554-53.460-07.6
Financing Cash Flow 299.02983.011363.584-301.786537.75472.516704.29510.653296.07161.71414.077102.74836.869137.229
Other Information:
Effect Of Forex Changes On Cash -20.7020.81511.5090.236-5.492-1.4592.79-3.5372.8091.128-0.1511.019-0.262-0.975
Net Change In Cash -18.906-125.608-35.499-74.994394.978185.678-32.65342.61641.99617.085-2.79-5.43814.973-15.115
Cash At End Of Period 434.251453.157578.764614.263689.257294.279108.601141.25498.63856.64339.55742.34747.78532.812